Understanding how loss of certain lung cells affects aging and emphysema risk

Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema

NIH-funded research National Jewish Health · NIH-11017855

This study is looking at how certain cells in the lungs, called mesenchymal vascular progenitors, change as we age and how their loss might lead to lung problems like emphysema, especially in people who smoke, with the hope of finding new ways to help improve lung health for older adults.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNational Jewish Health NIH-funded
Lab location1 site (Denver, United States)
Project IDNIH-11017855 on NIH RePORTER

What this research studies

This research investigates the role of mesenchymal vascular progenitors (MVPC) in lung aging and the development of emphysema. It aims to understand how the depletion of these cells contributes to vascular remodeling and increased susceptibility to lung diseases. By using both in vivo and in vitro models, the research will explore the regulation of MVPC function in healthy and aged lungs, as well as the consequences of their loss in various conditions, including exposure to cigarette smoke. The findings could lead to new therapeutic strategies to restore lung function and improve health outcomes for aging individuals.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults, particularly those at risk for or suffering from lung diseases such as emphysema.

Not a fit: Patients who are younger than 21 or do not have any lung-related health issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve lung health and reduce the risk of emphysema in older adults.

How similar studies have performed: Other research has shown promising results in understanding the role of progenitor cells in lung health, indicating that this approach has potential for success.

Where this research is happening

Denver, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.